Last updated on June 2020

A Phase 2b Study of Icosabutate in Fatty Liver Disease

Brief description of study

A Phase 2b study to evaluate the efficacy of different doses of NST-4016 on the resolution of NASH without worsening of fibrosis

Detailed Study Description

This is a 62 week (including screening and follow-up), multicenter, randomized, double blind, placebo-controlled, parallel group study in male and female patients with a histological diagnosis of NASH. The study includes a screening period, double blind treatment period, and post-treatment follow up

Clinical Study Identifier: NCT04052516

Find a site near you

Start Over

Florida Research Institute

Lakewood Ranch, FL United States
  Connect »

Covenant Research LLC

Sarasota, FL United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.